Isabelle Flandin-Gabelle

Grenoble, FR 
Grenoble, FR 

Overview

Isabelle Flandin-Gabelle practices practicing medicine in Grenoble, France.

Her clinical expertise encompasses Breast Cancer and Anaplastic Large Cell Lymphoma.

She is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Grenoble, 38000, France
Other Locations
La Tronche, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone, for Triple Negative Locally Advanced Breast Cancers and Luminal B Proliferating, Inaccessible to a Conservative Surgery the Outset
Comparing Sequential Neoadjuvant Treatment Including Chemotherapy and Accelerated Radiation Focused to the Tumor Bed vs Neoadjuvant Chemotherapy Alone, for Triple Negative Locally Advanced Breast Cancers and Luminal B Proliferating, Inaccessible to a Conservative Surgery the Outset
Enrollment Status: Terminated
Publish Date: December 29, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2

9 Total Publications

Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial.
Economic evaluation and budget-impact of accelerated partial breast irradiation (APBI) versus standard or hypofractionated whole breast irradiation (WBI) in postmenopausal women with early-stage breast cancer. Results from the French SHARE randomized trial.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 19, 2023

Frequently Asked Questions about Isabelle Flandin-Gabelle

Is Isabelle Flandin-Gabelle a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Isabelle Flandin-Gabelle is classified as an Experienced expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Isabelle Flandin-Gabelle participate in research or clinical trials?

Yes. Isabelle Flandin-Gabelle has published 9 articles and abstracts on conditions like Breast Cancer. You can view a list of Isabelle Flandin-Gabelle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Flandin-Gabelle's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile